"Immunoglobulin E" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
| Descriptor ID |
D007073
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.312 D12.776.124.790.651.114.619.312 D12.776.377.715.548.114.619.312
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin E".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin E".
This graph shows the total number of publications written about "Immunoglobulin E" by people in this website by year, and whether "Immunoglobulin E" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 2 | 3 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 3 | 4 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 2 | 3 |
| 2013 | 1 | 2 | 3 |
| 2014 | 3 | 0 | 3 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 3 | 3 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 6 | 6 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulin E" by people in Profiles.
-
Grunwell JR, Fitzpatrick AM. Asthma Phenotypes and Biomarkers. Respir Care. 2025 06; 70(6):649-674.
-
Asadi-Pooya AA, Malekpour M, Taherifard E, Mallahzadeh A, Farjoud Kouhanjani M. Coexistence of temporal lobe epilepsy and idiopathic generalized epilepsy. Epilepsy Behav. 2024 Feb; 151:109602.
-
Inan S, Ward SJ, Baltazar CT, Peruggia GA, Javed E, Nayak AP. Epicutaneous Sensitization to the Phytocannabinoid ?-Caryophyllene Induces Pruritic Inflammation. Int J Mol Sci. 2023 Sep 20; 24(18).
-
Asadi-Pooya AA, Farazdaghi M, Asadi-Pooya H, Fazelian K. Depression, anxiety, stress, and suicide risk in patients with functional seizures vs. those with epilepsy. Acta Neurol Belg. 2024 Feb; 124(1):169-173.
-
Asadi-Pooya AA, Fattahi D, Abolpour N, Boostani R, Farazdaghi M, Sharifi M. Epilepsy classification using artificial intelligence: A web-based application. Epilepsia Open. 2023 12; 8(4):1362-1368.
-
Asadi-Pooya AA, Farazdaghi M, Asadi-Pooya H, Fazelian K. Attention deficit hyperactivity disorder in patients with seizures: Functional seizures vs. epilepsy. J Clin Neurosci. 2023 Sep; 115:20-23.
-
Asadi-Pooya AA, Farazdaghi M. Idiopathic generalized epilepsies: Which seizure type is more difficult to control? J Clin Neurosci. 2023 Aug; 114:93-96.
-
Hirsch E, French J, Scheffer IE, Bogacz A, Alsaadi T, Sperling MR, Abdulla F, Zuberi SM, Trinka E, Specchio N, Somerville E, Samia P, Riney K, Nabbout R, Jain S, Wilmshurst JM, Auvin S, Wiebe S, Perucca E, Mosh? SL, Tinuper P, Wirrell EC. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022 06; 63(6):1475-1499.
-
Asadi-Pooya AA, Farazdaghi M. Rational therapy with lamotrigine or levetiracetam: Which one to select? J Clin Neurosci. 2022 May; 99:49-52.
-
Skypala IJ, Jeimy S, Brucker H, Nayak AP, Decuyper II, Bernstein JA, Connors L, Kanani A, Klimek L, Lo SCR, Murphy KR, Nanda A, Poole JA, Walusiak-Skorupa J, Sussman G, Zeiger JS, Goodman RE, Ellis AK, Silvers WS, Ebo DG. Cannabis-related allergies: An international overview and consensus recommendations. Allergy. 2022 07; 77(7):2038-2052.